written on 23.05.2014

Leading Pfizer and AstraZeneca shareholder BlackRock wants the megamerger


Four times Pfizer has made offers to buy AstraZeneca and four times, the U.K. company has said no. But the world's largest money-management firm hopes in this case no doesn't mean no. BlackRock–which owns 8% of AstraZeneca and 6.8% of Pfizer–is encouraging discussions between the two companies, according to Bloomberg, which cited anonymous sources.